Orchestrating T and NK Cells for Tumor Immunotherapy Via NKG2A-targeted Delivery of a De Novo Designed IL-2Rβγ Agonist
Drug delivery（2025）
Key words
Immunotherapy,immune checkpoint inhibitor,IL-2R agonist,T and NK cell exhaustion,IgG-binding domain
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined